FeliAIM: The AIM Drug for Cat Kidney Disease

Where Toru Miyazaki's AIM injection stands in Japan, what the cat studies found, when it could reach the US, and what helps a cat with kidney disease now.

By La Petite Labs Editorial 9 min read

As Seen On

  • AVMA, American Veterinary Medical Association
  • Today’s Veterinary Business
  • Petfood Industry
Woman cuddling an orange-and-white cat and a silver tabby while holding a Hollywood Elixir box
Hollywood Elixir® Senior Cat Supplement

17 science-backed actives

From$50/moSave up to 47%Save up to 44%Shop Now
Contents

FeliAIM is an AIM protein injection for cats with chronic kidney disease, and as of November 2026 it isn't approved anywhere. Toru Miyazaki's company, IAM CAT, applied for approval in Japan on April 24, 2026.1 It isn't a vaccine, isn't sold in the US and has no announced price.

The best evidence so far is one small study. About 80% of 11 treated cats with advanced kidney disease were alive after a year, against 20% of 15 untreated cats.5 Here's where FeliAIM stands, what that study can and can't tell you, and what helps a cat with kidney disease today.

La Petite Labs publishes this guide and makes Hollywood Elixir, a supplement for dogs and cats. We're not affiliated with IAM CAT, the Institute for AIM Medicine or any company named here.

What is the new kidney drug for cats?

The new kidney drug for cats is FeliAIM. It's a drug made from AIM, a blood protein that helps clear dead-cell debris from injured kidneys.6 FeliAIM supplies a lab-made version of the protein, given by injection.810

It comes from Toru Miyazaki's Institute for AIM Medicine and its company, IAM CAT, in Tokyo. IAM CAT filed it in Japan as a veterinary drug for chronic kidney disease, which is common in older cats.1 Guidelines put kidney disease in 28% to 81% of cats over 12, depending on the study.15

FeliAIM at a glance

What it is
A lab-made AIM protein drug for chronic kidney disease in cats
Developer
IAM CAT and the Institute for AIM Medicine, led by Toru Miyazaki
Status in Japan
Filed April 24, 2026; no approval announced as of November 2026
In the US
Not available; no US application announced
Is it a vaccine?
No; it supplies a protein instead of training the immune system
How it's given
Expected to be an injection into a vein at a vet clinic
Best evidence
11 treated cats: about 80% alive at 360 days, against 20% of 15 untreated cats
Price
Not announced

FeliAIM, AIM foods and today's kidney care compared

FeliAIMAIM-branded foods and supplementsToday's kidney care
What it isLab-made AIM proteinFood or supplement using the AIM nameRenal diet plus drugs matched to the stage
Contains AIM?YesNo; some add L-cystineNo
How it's givenExpected injection into a vein at a clinicEatenDiet at home; most drugs by mouth
Evidence in cats with kidney disease11-cat exploratory study; larger trial unpublishedNot confirmed in clinical studiesRenal diets shown to prolong survival
StatusFiled in Japan, April 2026Sold as foodAvailable now

Competitor label and pricing facts checked November 11, 2026. Sources are listed in the References section below.

Woman kneeling with two long-haired tabby cats while holding a Hollywood Elixir box beside a food bowl

Is FeliAIM approved in Japan?

Not yet. IAM CAT applied to Japan's Ministry of Agriculture, Forestry and Fisheries (MAFF) for approval to make and sell FeliAIM on April 24, 2026.1 As of November 10, 2026, the Institute for AIM Medicine's news page listed no approval after that notice.3

An application starts the review. It isn't a green light. MAFF's approval pages also note that updates can take time to appear.4 We'll update this page when IAM CAT or the ministry announces a decision.

Woman exercising beside a tabby cat, with a Hollywood Elixir box and food bowl on a small table

When will the AIM injection for cats be released?

There's no confirmed release date. The trial behind the application began in May 2025 at 26 veterinary hospitals across Japan, and IAM CAT filed for approval in April 2026.2101

In a September 2026 report, Miyazaki said the review was moving quickly because the ministry had sent fewer advance questions than expected. That fed talk of a Japanese launch as early as 2026.8 It's a hope, not a schedule. A launch needs approval first, then supply to vets, and Miyazaki has said Japan will be supplied first.8

Orange-and-white cat reaching toward a woman holding a Hollywood Elixir box while sitting in a chair

Is there a cure for cat kidney disease in Japan?

No. FeliAIM is the treatment people mean, and it's still under review. Even if it's approved, the evidence so far shows kidney blood markers worsening less in treated cats with advanced disease. It doesn't show damaged kidneys returning to normal.5

Chronic kidney disease in cats is progressive, and no treatment reverses it.9 Today's care aims to slow it and keep cats eating and comfortable, and it works best when it starts early.15

Gray-haired man holding a Hollywood Elixir box while two cats rest beside him in an armchair

Is FeliAIM available in the USA?

No. FeliAIM has only been filed in Japan, and we found no announcement of a US application as of November 2026. Approval in Japan doesn't carry over. A new animal drug sold in the US needs its own FDA approval or conditional approval.19

Be wary of anyone offering "AIM injections" in the US now. No approved product exists to sell. If you want the bigger picture on cat drugs in development, our cat longevity drug guide covers what's available and what's coming.

FeliAIM was filed for approval in Japan in April 2026. As of November 2026, it isn't approved anywhere.

Is Toru Miyazaki's AIM drug a cat vaccine?

No. FeliAIM is a protein drug, not a vaccine. A vaccine trains the immune system to make its own defense. FeliAIM supplies AIM protein directly, to make up for cat AIM that stays locked onto an antibody in the blood.68

The "vaccine" label has a history. A 2020 University of Tokyo feature said that, besides being given as a "preventative vaccine", the treatment was expected to work in cats whose kidney function had already declined.13 Blogs then ran with "AIM vaccine". What IAM CAT filed is a treatment for chronic kidney disease.1

Tabby cat looking up at a Hollywood Elixir sachet held above it, with the product box on a small table

How is the FeliAIM injection given?

FeliAIM is expected to be given by injection into a vein at a vet clinic. Miyazaki has explained that AIM is a protein, so it would be broken down in the gut if swallowed. He has also said it won't need frequent doses.10 In a 2023 talk, he said it wouldn't be given daily or weekly.12

An approved FeliAIM dose and schedule are not yet available. A Japanese vet hospital group expects the details to come out through the approval process.11

Hand gently petting an orange-and-white cat beside a food bowl and Hollywood Elixir box

What did the AIM cat studies find?

The main published study is a 2026 paper by Miyazaki's group in The Veterinary Journal. The team screened 216 cats with chronic kidney disease and chose advanced cases with blood creatinine between 2.9 and 5.0 mg/dL. Six cats got mouse AIM protein, five got cat AIM protein, and 15 went untreated.5

At 360 days, survival was about 83% and 80% in the two treated groups, against 20% in the untreated cats, whose median survival was 167 days. Kidney blood markers and uremic toxins worsened less in treated cats.5

That's a large signal from a very small study. The authors call it exploratory and non-pivotal. Nine untreated cats with lower levels of one uremic toxin all survived the year, a reminder that which cats are chosen shapes the result.5 The larger trial behind the application hasn't been published. Miyazaki has reportedly said 60 cats took part, but survival, safety and statistical details haven't been released.8

Man holding a Hollywood Elixir box beside a black cat, an orange tabby and a food bowl

How does AIM work in a cat's kidneys?

AIM normally travels in the blood attached to a large antibody called IgM. When the kidneys are injured, it lets go, passes into the urine and helps clear dead-cell debris that blocks the kidney's tubules.6

A 2016 study by Miyazaki's group found that cat AIM binds IgM about 1,000 times more tightly than mouse AIM. In cats, it stays bound during acute kidney injury, so the debris clears poorly. Giving AIM protein to mice with kidney injury improved their kidney function and survival.6 That's the idea behind FeliAIM: supply the free AIM that cats can't release.

Who is Toru Miyazaki?

Toru Miyazaki is the Japanese immunologist who discovered AIM. He first described it in 1999, while at the Basel Institute for Immunology in Switzerland, in a mouse study in the Journal of Experimental Medicine.714

He later became a professor at the University of Tokyo and left in 2022 to lead the Institute for AIM Medicine. He's also CEO of IAM CAT, the company that filed FeliAIM.141 When research funding for the cat drug ran short during the pandemic, cat owners donated nearly 300 million yen, about $2 million, between 2021 and 2022.9

In the only published treatment study, about 80% of 11 treated cats were alive at a year, against 20% of 15 untreated cats.

Woman holding a Hollywood Elixir box toward a brown cat perched on the back of a sofa

Could FeliAIM help cats live to 30?

That's a hope, not a finding. The "30 years" idea comes from Miyazaki's 2021 book, The Day Cats Live to Be 30. It argues that preventing and treating kidney disease could nearly double cats' average lifespan of about 15 years.814

Evidence has not shown that AIM extends healthy cats' whole lifespan. The 2026 study measured 360-day survival in cats that already had advanced kidney disease.5 FeliAIM was filed as a kidney disease treatment, not a lifespan drug.1 Our longevity shot guide covers the other viral claims.

Woman leaning toward a fluffy orange cat beside a Hollywood Elixir box and green food bowl

What are the side effects of the AIM injection?

Some safety observations have been published. The 2026 exploratory study reported no anaphylaxis or allergic reactions among its 11 rAIM-treated cats after repeated dosing. Anti-mouse AIM antibodies developed, with high levels in two cats; the assay was not validated, and an in-vitro test found no noticeable neutralizing effect.5 That small study cannot establish a complete safety profile. As of September 2026, safety data from the separate larger trial hadn't been disclosed.8 If FeliAIM is approved, its label will list identified risks.

What's known is practical. A drug given into a vein means trips to the clinic, unlike fluids you give at home.11 A 2020 University of Tokyo feature reported no side effects up to that point, but that was before the larger trial.13

Tabby cat licking its nose beside a food bowl and Hollywood Elixir box

How much will FeliAIM cost?

No price has been announced. IAM CAT hasn't published one, and a Japanese vet hospital group says the official price will come after approval.11

The only figure from Miyazaki himself is a 2023 hope. He said he'd like to bring the price down to the low tens of thousands of yen, or below ¥10,000 if possible.12 Treat any price you see online as a guess until IAM CAT publishes one.

Where can I buy AIM for cats?

You can't buy FeliAIM anywhere yet. It isn't approved, and the trial, which enrolled cats at IRIS stage 3, has ended, so there's no way to join.11 Anything sold online as an "AIM injection" isn't the drug IAM CAT filed.

What you can buy are foods and supplements that use the AIM name. They're a different thing, covered next.

Are AIM cat foods and supplements the same as FeliAIM?

No. FeliAIM delivers AIM protein by injection. AIM-branded foods don't contain AIM. Products such as AIM30 add L-cystine, an amino acid meant to activate a cat's own AIM, and their effect on kidney disease hasn't been confirmed in clinical studies. They're sold as regular food, not as therapeutic diets.11

Don't swap a prescribed renal diet for an AIM-branded food. The Japanese vet group above calls that a dangerous misconception.11 If you're weighing supplements for an older cat, our senior cat supplements guide explains what each kind can reasonably do.

Tabby cat sitting at a table with a food bowl and Hollywood Elixir box

How is cat kidney disease staged?

Vets stage chronic kidney disease in cats with the IRIS system, based on blood creatinine, often with SDMA, measured at least twice in a stable, hydrated cat. Creatinine below 1.6 mg/dL is stage 1, 1.6 to 2.8 is stage 2, 2.9 to 5.0 is stage 3, and above 5.0 is stage 4.15 Each stage is then substaged by protein in the urine and blood pressure.15

Staging matters for FeliAIM. The cats in the 2026 study had creatinine of 2.9 to 5.0, which is IRIS stage 3, and the trial enrolled stage 3 cats.511 Whether AIM helps at earlier or later stages hasn't been studied.

Woman cuddling a silver tabby and a cream-colored cat while holding a Hollywood Elixir box

What can I do for a cat with kidney disease now?

Don't wait for FeliAIM. Kidney disease keeps progressing during any approval process, and today's care makes a real difference.11 Work with your vet on these:

  • A renal diet. Guidelines rate the evidence as strong: a therapeutic kidney diet can prolong survival and reduce uremic crises, mainly by limiting phosphorus.15 Our senior cat diet guide covers feeding an older cat.
  • Urine protein and blood pressure. If protein in the urine stays high, guidelines pair a renal diet with a drug such as telmisartan or benazepril.15 Telmisartan (Semintra) is also FDA-approved to control high blood pressure in cats.16 Our telmisartan for cats guide explains how it's used.
  • Water. Encourage drinking with fresh water, wet food and extra water stations.11
  • Rechecks. Bloodwork, urine tests and blood pressure every three to six months, or on the schedule your vet sets.11

If your cat is drinking more, losing weight or eating less, see your vet. Kidney disease often shows few signs early, so guidelines suggest weight checks, blood tests and urine tests from age 7, and health checks twice a year after 10.15

Where daily nutrition fits

We make Hollywood Elixir, a daily nutrition powder for adult and senior dogs and cats. It's built around nicotinamide riboside, an NAD+ precursor, with CoQ10, glutathione and 14 more actives, and every active amount is printed on the label. It's a supplement, not a FeliAIM substitute: it isn't designed to do what FeliAIM does, it isn't a kidney treatment, and it hasn't been tested for lifespan. Its case is practical: one daily sachet stirred into food (half for pets under 7 lb, two for dogs over 30 lb) instead of a cupboard of separate supplements. If your cat has kidney disease or takes any medication, check with your vet before adding it or any other supplement, and keep feeding the diet your vet prescribed. See the full formula and serving guide.

Kidney disease doesn't wait for approvals. A renal diet and your vet's plan help now.

Educational content only. This material is not a substitute for veterinary advice. Always consult your veterinarian about your cat’s specific needs. These statements have not been evaluated by the Food and Drug Administration. Products mentioned are not intended to diagnose, treat, cure, or prevent any disease.

Glossary

AIM: apoptosis inhibitor of macrophage, a blood protein, also called CD5L, that helps clear dead-cell debris.

IgM: a large antibody in the blood that AIM normally travels attached to.

Recombinant protein: a protein made in the lab from its gene, for use as a drug.

IRIS staging: the International Renal Interest Society's four-stage system for chronic kidney disease, based mainly on creatinine.

Indoxyl sulfate: a uremic toxin that builds up in the blood as the kidneys fail.

MAFF: Japan's Ministry of Agriculture, Forestry and Fisheries, which approves veterinary drugs.

Related Reading

References

Sources and further detail

  1. Institute for AIM Medicine (24 April 2026), *Notice of the manufacturing and marketing approval application for the AIM cat drug FeliAIM* (in Japanese)
  2. Institute for AIM Medicine (13 June 2025), *The clinical trial for the AIM cat medicine has begun*
  3. Institute for AIM Medicine, *News* (in Japanese, checked 10 November 2026)
  4. Ministry of Agriculture, Forestry and Fisheries, National Veterinary Assay Laboratory, *Approval and review information* (in Japanese, checked November 2026)
  5. Tezuka T, Arakawa H, Kudo K et al. *The Veterinary Journal* (2026). A clinical impact of apoptosis inhibitor of macrophage on feline chronic kidney disease
  6. Sugisawa R, Hiramoto E, Matsuoka S et al. *Scientific Reports* (2016). Impact of feline AIM on the susceptibility of cats to renal disease
  7. Miyazaki T, Hirokami Y, Matsuhashi N et al. *Journal of Experimental Medicine* (1999). Increased susceptibility of thymocytes to apoptosis in mice lacking AIM, a novel murine macrophage-derived soluble factor
  8. EDAILY (2 Sept 2026), "My cat will live to be 30?" The truth behind the buzz surrounding a new Japanese drug
  9. AFP via Free Malaysia Today (27 April 2026), Japan startup seeks approval of cat kidney disease treatment
  10. Neko no Kimochi, Benesse (updated 20 Oct 2025), *Interview with the developer of the new AIM drug for cats* (in Japanese)
  11. Noah Animal Hospital Group, *AIM: a complete guide* (in Japanese, as of July 2026)
  12. Felissimo Nekobu (18 March 2023), *Talk event with Toru Miyazaki, part 2* (in Japanese)
  13. University of Tokyo (9 Jan 2020), *Aiming to double cats' lifespan*
  14. Tokyo Shimbun (29 Jan 2023), *Extending cats' lives to 30: a kidney drug nears completion* (in Japanese)
  15. Taylor S, Finch N, Caney S et al. *Journal of Feline Medicine and Surgery* (2026). 2026 iCatCare consensus guidelines on the diagnosis and management of chronic kidney disease in cats
  16. dvm360 (24 May 2018), *FDA approves first drug for systemic hypertension in cats*
  17. The Vanguard Report (updated 28 Jan 2025), *New medical breakthrough means cats could live till 30 years old*
  18. FDA (14 March 2025), *FDA conditionally approves drug for management of ventricular hypertrophy in cats*
  19. FDA, *FDA regulation of animal drugs*

FAQ

What is FeliAIM?

FeliAIM is a lab-made AIM protein drug for chronic kidney disease in cats, from Toru Miyazaki's company IAM CAT in Tokyo. It was filed for approval in Japan on April 24, 2026. As of November 2026, it isn't approved or sold anywhere.

What is AIM in cats?

AIM, short for apoptosis inhibitor of macrophage, is a blood protein that helps clear dead-cell debris from injured kidneys. In cats it binds an antibody in the blood so tightly that it isn't released when the kidneys need it. That may help explain why kidney disease is so common in cats.

When did Toru Miyazaki discover AIM?

Miyazaki first described AIM in 1999, in a mouse study published while he was at the Basel Institute for Immunology in Switzerland. His group later linked it to kidney disease in cats, in a 2016 study.

Can my cat join the FeliAIM clinical trial?

No. The trial ran at 26 veterinary hospitals in Japan for cats at IRIS stage 3, and it has ended. There's no open enrollment in Japan or abroad.

Is FeliAIM a pill?

No. AIM is a protein, so it would be broken down in the gut if swallowed. It's expected to be given by injection into a vein at a vet clinic, and not daily or weekly.

Will FeliAIM work for cats with early kidney disease?

No one knows yet. The published study and the trial focused on cats with creatinine of 2.9 to 5.0 mg/dL, which is IRIS stage 3. Earlier stages haven't been tested.

How many cats were in the FeliAIM trial?

The trial ran at 26 hospitals across Japan from 2025, and Miyazaki has reportedly said 60 cats took part. Its full results, including side effects, haven't been published as of November 2026.

Did AIM improve cats' organ function by 35%?

We couldn't find any study that reports that number. It appears in a 2025 web article that names no trial.17 The published cat study measured survival and kidney blood markers, not a 35% gain.

Is FeliAIM the same as Felycin-CA1?

No. Felycin-CA1 is a weekly sirolimus tablet that the FDA conditionally approved in March 2025 for heart-wall thickening in cats with early, symptom-free heart disease (subclinical HCM).18 FeliAIM is a kidney disease drug filed only in Japan. Our Felycin-CA1 guide covers the heart drug.

Orange-and-white cat beside a Hollywood Elixir box held in a person's hand

Discover LPL-01: How This Fits Into a Larger Feline Longevity System

Aging in cats unfolds quietly. It’s not driven by a single failure, but by gradual shifts across interconnected systems — cellular energy, oxidative balance, immune tone, and tissue integrity — each influencing the others over time.

This article explores one layer of that system. To understand what actually shapes long-term health, you need to step back and look at how these layers interact.

Start with the underlying science: